Navigation Links
Spaulding Clinical Welcomes Dr. Aziz Karim, Clinical Pharmacokinetic Consultant
Date:4/11/2011

WEST BEND, Wis., April 11, 2011 /PRNewswire/ -- Leading-edge Clinical Pharmacology and Cardiac Core Lab provider, Spaulding Clinical Research, LLC proudly announces the addition of Aziz Karim, BPharm, PhD, FCP, ABCP to their team as a consultant and advisor to Spaulding's Clinical Pharmacology/Pharmacokinetic department.  

Dr. Karim's expertise lies in the principles of Clinical Pharmacology and rational drug development including the design of drug-drug interaction and bioavailability/bioequivalence studies. With over 30 years of experience in Pharmaceutical Sciences and Clinical Pharmacology, he has contributed to the development and marketing approvals of over 30 NCEs and/or Novel Drug Delivery Systems and has interfaced extensively with global regulatory bodies.  Most recently, Dr. Karim was the Vice President of Global Clinical Pharmacology at Takeda Pharmaceuticals.  Prior to Takeda, he held the role of Distinguished Scientist & Senior Director of Clinical Pharmacology for G.D. Searle & Co. and Pharmacia.

Daniel Selness, General Manager and Senior Vice President of Operations, commented, "Aziz's understanding of early clinical development, ability to design appropriate pharmacology trials/programs, and analysis expertise are wonderful complements to our existing services. Pharmacokinetic design and analysis is an imperative part of NCE development and if not approached correctly, may result in significant delays to programs.  Keeping with our company goals, his experience will continue to improve clinical trials, ultimately leading to safer drugs in the marketplace." 

CEO Randol Spaulding stated, "The addition of Aziz's experience and skills furthers our ability to be a 'one-stop-shop' for pharmaceutical companies throughout the world.  We continue to focus on being the innovation leader in the industry."

To learn more about how Spaulding can assist with your Clinical Pharmacology programs or Pharmacokinetic analysis, please contact us at SpauldingPK@spauldingclinical.com or 262-306-3331.  Spaulding Clinical will be demonstrating their cutting edge "Spaulding IQ" ECG device and Protocol from June 19 – 22, 2011 in booth 1905 at the DIA meeting in Chicago, Illinois. 

About Spaulding Clinical

Spaulding Clinical Research, LLC (www.spauldingclinical.com) is a Clinical Pharmacology Research Unit and Cardiac Core Lab that offers a full range of global services from study design through study execution/conduct, data management, statistical analysis, and clinical summary/expert reporting. Spaulding has extensive experience conducting TQT, first-in-human, multiple rising dose, bioavailability/bioequivalence, drug interaction, and food effect studies. As a Phase 1-4 Core Lab provider, Spaulding offers the complete suite of equipment provisioning and electrocardiogram over-reading services with state-of-the-art technologies and expertly trained cardiologists.


'/>"/>
SOURCE Spaulding Clinical Research, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt®
2. Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
3. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
4. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
5. Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System
6. OmniComm Systems Awarded 4 Clinical Trials from U.S. Biotechnology Company
7. Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors
8. Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session
9. Sofie Biosciences Launches a High Performance, Benchtop Preclinical PET System Using New Generation Detector Technology
10. Data From Landmark Clinical Trial of Abbotts MitraClip® System Demonstrate Durable Clinical Benefits for Patients With Mitral Regurgitation Two Years After Treatment
11. Publication in SLEEP Journal Demonstrates Positive Results of Large Multi-Center Clinical Trial for Provent® Sleep Apnea Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
Breaking Medicine News(10 mins):